Lesia K Dropulic

7PUBLICATIONS
62CO-AUTHORS
NanomedicineRespiratory diseasesInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial.

Aurélie Ploquin, Rosemarie D Mason, LaSonji A Holman

|Dec 31, 2025
Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles to Elicit Broad Antibody Responses.

Christian K O Dzuvor, Sydney Moak, Lindsay R McManus

|Oct 14, 2025
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses.

Alexandra A Abu-Shmais, Gray Freeman, Adrian Creanga

|Jan 01, 2025
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem-specific human B cells.

Grace E Mantus, Ankita J Chopde, Jason Gorman

|Sep 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.

Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner

|Apr 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.

Alicia T Widge, Amelia R Hofstetter, Katherine V Houser

Pageof 2